A novel activin signaling inhibitor for the treatment of pulmonary arterial hypertension: sotatercept

doi:10.3969/j.issn.1672-3384.2024.10.003

PDF(420 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (10) : 12-15. DOI: 10.3969/j.issn.1672-3384.2024.10.003

Comment of New Drug

A novel activin signaling inhibitor for the treatment of pulmonary arterial hypertension: sotatercept

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(10): 12-15 https://doi.org/10.3969/j.issn.1672-3384.2024.10.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(420 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-05-05	2024-10-20
Issue Date
2024-12-25

Please choose a citation manager

Content to export